查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1133468

2022-2029 年心臟 MRI 检查的全球市场

Global Cardiac MRI Testing Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

心臟 MRI 检查市场的增长是由心血管疾病患病率上升、老年人口增加、技术进步和研究活动推动的。

预计心血管疾病患病率上升将推动市场增长。

预计久坐生活方式的增加将在预测期内提振市场。根据世界卫生组织 (WHO) 的数据，心血管疾病 (CVD) 是全球死亡的主要原因。 2021 年 6 月的数据估计每年有 1790 万人死亡。缺乏运动、不健康的饮食、吸烟和酒精的有害影响都是心脏病和中风的危险因素。这些危险因素与高血压、血糖失衡、血脂失衡、超重和肥胖有关。 MRI 扫描用于识别这些高阶 CVD 风险。

此外，根据 2022 年 4 月发表在《美国心脏病学会杂誌》上的一项研究，预计到 2060 年，美国心血管危险因素和疾病的发病率将显着增加。心血管疾病趋势的显着增加可能会增加美国医疗保健系统的负担，以及现在需要预防教育和公平获得治疗以预防未来的疾病。成为焦点。此外，2021 年 6 月，世卫组织发布了一份用于管理心血管疾病的优先医疗器械清单，包括用于医学成像的 MRI，从而推动了全球心臟 MRI 市场。

其他成像选项的可用性阻碍了市场增长

但是，市场上存在的替代成像选项（例如心血管成像模式）限制了心臟 MRI 检查市场。此外，由于医疗保健技术的进步，医疗费用呈上升趋势。

COVID-19 影响分析

COVID-19 的出现对全球心臟 MRI 检测市场产生了相当大的影响。 COVID-19 感染已像野火一样在世界各地蔓延。它主要影响呼吸系统。 COVID-19 与心肌损伤有关，通常直接通过病毒感染或间接通过全身炎症和内皮激活。心臟 MRI 对诊断心肌炎患者至关重要，因此在大流行期间增加了对心臟 MRI 检查的需求。随着大流行中患者数量的增加，对心臟核磁共振检查的需求也在增加。然而，在大流行期间，强制性封锁和交通限制使进入医疗设施变得困难。另一方面，对于 COVID-19 患者，老年人面临着缺乏心脏病诊断和常规治疗的问题。它影响了心臟 MRI 检查市场的大小市场参与者。但是，到 2022 年年中，情况已经从 COVID-19 中恢復过来。市场增长机会可能会出现。

全球心臟 MRI 检查市场报告将提供对大约 40 多个市场数据表、45 多个数字和 200 多页（大约）的访问。

内容

第一章市场研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按应用划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 心血管疾病发病率上升
      • 研究活动增加
    • 约束因素
    • 其他成像选项的可用性
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析
  • 定价分析
  • 未满足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按应用程序

  • 影像诊断
  • 病人监护
  • 影像引导治疗

第 8 章最终用户

  • 医院和诊所
  • 心脏病诊所
  • 门诊手术中心
  • 诊断中心
  • 其他

第 9 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 10 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 应用基准测试

第 11 章公司简介

  • Koninklijke Philips N.V.
    • 公司概况
    • 应用组合和说明
    • 主要亮点
    • 财务摘要
  • FUJIFILM Corporation
  • Canon Inc.
  • NeoSoft LLC
  • Siemens Healthcare Private Limited
  • Pie Medical Imaging
  • Medis Medical Imaging
  • Symphony Innovation, LLC
  • Circle Cardiovascular Imaging Inc
  • GE Healthcare

第 12 章心臟 MRI 全球市场-DataM

简介目录
Product Code: DMCD5861

Market Overview

Cardiac MRI Testing Market Size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of X% during the forecast period (2022-2029).

Cardiac MRI testing is a scan of a patient's heart in which radio waves and magnets build images without any side effects for the patient's body. An MRI scan is able to show parts of the heart, including chambers and valves, and how they are working. A cardiac MRI scan can diagnose heart problems such as heart failure, heart valve disease, heart muscle inflammation or infection, and other conditions.

Market Dynamics

The cardiac MRI testing market growth is driven by the rise in the prevalence of cardiovascular diseases, the increase in the geriatric population, technological advancements, and research activities.

The rising prevalence of the cardiovascular disease is expected to drive the market growth

The rising sedentary lifestyle is expected to boost the market over the forecast period. As per the World Health Organization, cardiovascular diseases (CVD) are the main cause of death worldwide. As per the June 2021 data, It is estimated that 17.9 million die each year. Physical inactivity, an unhealthy diet, tobacco use, and the harmful effects of alcohol are all risk factors for heart disease and stroke. These risk factors are associated with high blood pressure, blood glucose imbalance, blood lipid imbalance, overweight, and obesity. MRI testing is used to identify these high-level risks of CVDs.

Furthermore, in the April 2022, as per the study published report in the Journal of the American College of Cardiology, By the year 2060, it is expected that rates of cardiovascular risk factors and disease will increase significantly in the United States. Considerable increases in cardiovascular trends may contribute to an increasing burden on the U.S. health care system and spotlight the necessity for impartial access to precaution education and treatments now to prevent future disease. Moreover, in June 2021, the WHO published a list of priority medical devices for management of cardiovascular diseases, including MRI for medical imaging, which boosted the cardiac MRI market worldwide.

The availability of other imaging options will hamper the growth of the market

However, the availability of alternative imaging options such as cardiovascular imaging modalities in the market limits the cardiac MRI testing market. In addition, healthcare costs are increasing due to the advancement in healthcare technology.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global cardiac MRI testing market. COVID-19 infection spread like wildfire around the world. It primarily affects the respiratory system. COVID-19 is associated with myocardial injury, which is more common and can occur directly due to viral infection or indirectly due to systemic inflammation or endothelial activation. As cardiac MRI is important for the diagnostic process of patients with myocarditis, results in an increasing demand for cardiac MRI testing during a pandemic. As the pandemic's case count increased, so did the demand for cardiac MRI testing. However, due to the enforced lockdown and transportation restrictions, access to the health care system was difficult during the pandemic. On the Other hand, for COVID-19 patients, the elderly population faces a lack of diagnosis and regular treatment for heart disease. It has an impact on the large and small market players in the cardiac MRI testing market. But, in the middle of 2022, the situation is recovering from COVID-19. There will be an opportunity for market growth.

Segment Analysis

The patient monitoring segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The patient monitoring segment is expected to boost the market over the period of the forecast. This is owing to the increased prevalence of cardiovascular disease, a rise in the geriatric population, and health issues occurring in the COVID-19 pandemic, which results in an increasing demand for monitoring of patients to diagnose the diseases. Cardiac MRI is an accurate and effective solution for monitoring the heart health of patients with different diseases such as arrhythmias, abnormal heartbeats, and heart failure.

According to Census Bureau estimations, by 2030, the number of people aged 65 and older in the United States will increase faster than the young population (aged 18 and under). The older population suffers from a greater degree of health issues than the younger population, resulting in shifting demand for monitoring solutions to diagnose, track and treat health issues such as cardiovascular disease.

Geographical Analysis

North American region holds the largest market share of the global Cardiac MRI testing market

North America dominates the market for cardiac MRI testing and is expected to show a similar trend over the forecast period. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to advancements in healthcare infrastructure and the availability of diagnostic imaging systems for heart disease. According to the centers of disease control and prevention, heart disease is the leading cause of death in people in different age groups in the United States region. One person dies every 34 seconds because of cardiac disease.

In 2020, around 697,000 people in the United States die from heart disease. In the population with Cardiac Artery Disease (CAD), about 20.1 million adults age 20 and older have CAD (about 7.2%). In the United States, 805,000 have heart attacks every year. As the population with CVD increases in the North American region, the demand to diagnose the disease results in an increasing demand for MRI testing in the region. Technological advancements boost the market growth in the North American region. For instance, in September 2022, University of Minnesota Twin Cities scientists and their team found a solution to upgrade the performance of traditional (MRI) reconstruction techniques, enabling faster MRIs to improve healthcare.

Competitive Landscape

The cardiac MRI testing market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market are Koninklijke Philips N.V, FUJIFILM Corporation, Canon Inc., NeoSoft LLC, Siemens Healthcare Private Limited, Pie Medical Imaging, Medis Medical Imaging, Symphony Innovation, LLC, Circle Cardiovascular Imaging Inc., and GE Healthcare among others. The major players are adopting several growth strategies such as new product launches, acquisitions, and collaborations, which are contributing to the growth of the cardiac MRI testing market globally.

For instance,

  • In February 2022, GE Healthcare received approval from the European Medicines Agency (EMA) for additional imaging modalities for its stress agent Rapiscan (Regadenoson). Rapiscan is approved for use in Magnetic Resonance Imaging (MRI) as well as Computed Tomography (CT) and Positron Emission Tomography (PET).

Canon Medical Systems Corporation

Overview:

Canon Medical Systems Corporation is a Japanese multinational corporation headquartered in Tokyo, Japan. The company offers a broad range of diagnostic medical imaging solutions, including CT, MR, X-Ray, ultrasound, and healthcare informatics, across the globe. It offers imaging solutions for ischemic heart disease, structural heart disease, and congenital heart disease.

Product Portfolio:

k-t SPEEDER: This MR imaging technology provides up to 8x faster frame rate cardiac cine and perfusion with free breathing. It is easy to use for patients and offers images a wide range of heart patients. In addition, it also helps to acquire high temporal resolution cardiac cine without compromising patient comfort.

The global cardiac MRI testing market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Application
  • 3.2. Market snippet By End User
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising incidences of cardiovascular diseases
      • 4.1.1.2. The increasing number of research activities
    • 4.1.2. Restraints:
    • 4.1.3. Availability of other imaging options
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 7.1.2. Market Attractiveness Index, By Application Segment
  • 7.2. Diagnostic Imaging*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Patient Monitoring
  • 7.4. Image Guided Treatment

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals and Clinics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Cardiovascular Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Diagnostics Centres
  • 8.6. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. The U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Application Benchmarking

11. Company Profiles

  • 11.1. Koninklijke Philips N.V.*
    • 11.1.1. Company Overview
    • 11.1.2. Application Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. FUJIFILM Corporation
  • 11.3. Canon Inc.
  • 11.4. NeoSoft LLC
  • 11.5. Siemens Healthcare Private Limited
  • 11.6. Pie Medical Imaging
  • 11.7. Medis Medical Imaging
  • 11.8. Symphony Innovation, LLC
  • 11.9. Circle Cardiovascular Imaging Inc
  • 11.10. GE Healthcare

LIST NOT EXHAUSTIVE

12. Global Cardiac MRI Testing Market- DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us